Modulation of the mRNAs encoding substance P and its receptor in rat macrophages by LPS.
Numerous soluble factors and their receptors contribute to the regulation of immune responses. An important area of investigation concerns defining the regulation of expression of such receptor/ligand pairs, since understanding such events are central in the quest to manipulate immune responses. Receptors for the neuropeptide, substance P, are present on a variety of leukocytes, and these receptor positive cells respond to in vitro stimulation with substance P in a variety of ways. Unfortunately, little is known about the regulation of expression of substance P or its receptor in leukocytes. Here we begin to address this question by examining the ability of macrophages to express mRNAs which encode substance P and its receptor. A radiolabeled oligonucleotide probe complementary to the mRNA which encodes substance P (i.e., preprotachykinin mRNA) hybridized to a 1.3 kb RNA species present in rat macrophages. In addition, the expression of this RNA could be upregulated 6 to 8 fold when macrophages were stimulated with LPS. The ability of macrophages to synthesize and secrete immunoreactive-substance P was demonstrated by incorporation of L-[35S]methionine into material from macrophage cultures which could be recognized by a monoclonal antisubstance antibody. Macrophage RNA of approximately 3.1 kb in size was capable of hybridizing with an oligonucleotide probe complementary to rat brain substance P receptors. In addition, this RNA could be upregulated when cells were exposed to LPS. Taken together, these studies suggest that the genes used by neuronal cells and macrophages to encode substance P and its receptor are similar if not identical.(ABSTRACT TRUNCATED AT 250 WORDS)
Bost
K L
KL
Department of Microbiology and Immunology, Tulane University Medical Center, New Orleans, LA 70112.
Breeding
S A
SA
Pascual
D W
DW
D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D004731:Endotoxins / Q000494:pharmacology*; D005260:Female; D007941:Leukemia P388 / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D008070:Lipopolysaccharides; D008264:Macrophages / Q000187:drug effects* / Q000378:metabolism; D008969:Molecular Sequence Data; D015213:Neuroimmunomodulation; D011498:Protein Precursors / Q000235:genetics; D012323:RNA Processing, Post-Transcriptional / Q000187:drug effects*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism*; D012334:RNA, Neoplasm / Q000235:genetics; D051381:Rats; D011919:Rats, Inbred Strains; D018040:Receptors, Neurokinin-1; D017981:Receptors, Neurotransmitter / Q000235:genetics*; D013373:Substance P / Q000235:genetics* / Q000378:metabolism; D015320:Tachykinins / Q000235:genetics
D004731:Endotoxins; D008070:Lipopolysaccharides; D011498:Protein Precursors; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D018040:Receptors, Neurokinin-1; D017981:Receptors, Neurotransmitter; D015320:Tachykinins; C044206:preprotachykinin; D013373:Substance P